NCT01936337View on ClinicalTrials.gov

Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Psoriasis Vulgaris
Interventions
DRUG

DLX105 Hydrogel

topical administration on psoriatic plaque

DRUG

Placebo

topical administration on psoriatic plaque

Trial Locations (3)

Unknown

University Hospital AKH, Vienna

University Hospital, Münster

University Hospital, Tübingen

Sponsors
All Listed Sponsors
lead

Delenex Therapeutics AG

INDUSTRY